Skip to main content
Figure 3 | Retrovirology

Figure 3

From: The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

Figure 3

Synergistic inhibition of HIV-1 replication by drug combinations analyzed by the isobologram analysis. (A) The combination of TFV+FTC with an ADA value of -0.37 (p < 0.001); (B) The combination of TFV+EFV with an ADA value of -0.14 (p < 0.03); (C) The combination of FTC+EFV with an ADA value of -0.23 (p < 0.001). The diagonally drawn solid line (in red) represents additivity.

Back to article page

Retrovirology

ISSN: 1742-4690

Contact us